| 1 | [SID51086249] | Active | EC50 | 4.974 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | EC50 | 4.974 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 2 | [SID51086249] | Active | EC50 | 4.974 | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | EC50 | 4.974 [uM] | | BioAssay | Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 588407 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 3 | [SID51086249] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant [AID1530, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant | | AID | 1530 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 4 | [SID51086249] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant [AID1530, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant | | AID | 1530 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 5 | [SID51086249] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype [AID1531, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype | | AID | 1531 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 6 | [SID51086249] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype [AID1531, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype | | AID | 1531 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 7 | [SID51086249] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 8 | [SID51086249] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504904, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504904 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 9 | [SID51086249] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 10 | [SID51086249] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 11 | [SID51086249] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 12 | [SID51086249] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 13 | [SID51086249] | Inactive | Potency | 22.3872 | qHTS of TDP-43 Inhibitors [AID652104, Type: confirmatory] | TAR DNA-binding protein 43 [gi:20140568] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS of TDP-43 Inhibitors | | AID | 652104 | | BioAssay type | confirmatory | | Target | TAR DNA-binding protein 43 [gi:20140568] | | PubMed | | | Data Table |  |
|
| 14 | [SID51086249] | Inactive | EC50 | 26.183 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | 26.183 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 15 | [SID51086249] | Inactive | EC50 | 26.183 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | 26.183 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 16 | [SID51086249] | Inactive | EC50 | 26.183 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | 26.183 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 17 | [SID51086249] | Inactive | EC50 | 26.183 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization [AID588435, Type: confirmatory] | OPRM1 gene product [Homo sapiens] [gi:117940060] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | 26.183 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization | | AID | 588435 | | BioAssay type | confirmatory | | Target | OPRM1 gene product [Homo sapiens] [gi:117940060] | | PubMed | | | Data Table |  |
|
| 18 | [SID51086249] | Inactive | EC50 | 30.822 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | 30.822 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 19 | [SID51086249] | Inactive | EC50 | 30.822 | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization [AID588411, Type: confirmatory] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | 30.822 [uM] | | BioAssay | Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRD1 homodimerization | | AID | 588411 | | BioAssay type | confirmatory | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 20 | [SID51086249] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 21 | [SID51086249] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 22 | [SID51086249] | Inactive | EC50 | 92.468 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | 92.468 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 23 | [SID51086249] | Inactive | EC50 | 92.468 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | 92.468 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 24 | [SID51086249] | Inactive | EC50 | 92.468 | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID588408, Type: confirmatory] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | 92.468 [uM] | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based high throughput dose response assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 588408 | | BioAssay type | confirmatory | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 25 | [SID51086249] | Inactive | Potency | 100 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 26 | [SID51086249] | Inactive | Potency | 100 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 27 | [SID51086249] | Inactive | Potency | | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 28 | [SID51086249] | Inactive | Potency | | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588456, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588456 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 29 | [SID51086249] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 30 | [SID51086249] | Inactive | Potency | | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 [AID2676, Type: confirmatory] | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Agonists of the Relaxin Receptor RXFP1 | | AID | 2676 | | BioAssay type | confirmatory | | Target | relaxin receptor 1 isoform 1 [Homo sapiens] [gi:85986601] | | PubMed | | | Data Table |  |
|
| 31 | [SID51086249] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 32 | [SID51086249] | Inactive | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 33 | [SID51086249] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 34 | [SID51086249] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) [AID488975, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT) | | AID | 488975 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 35 | [SID51086249] | Inactive | | | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493012, Type: screening] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493012 | | BioAssay type | screening | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 36 | [SID51086249] | Inactive | Potency | | qHTS for Inhibitors of Vif-A3G Interactions: qHTS [AID602310, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3G Interactions: qHTS | | AID | 602310 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 37 | [SID51086249] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 38 | [SID51086249] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 39 | [SID51086249] | Inactive | EC50 | | uHTS luminescence assay for the identification of compounds that inhibit NOD2 [AID1566, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | EC50 | [uM] | | BioAssay | uHTS luminescence assay for the identification of compounds that inhibit NOD2 | | AID | 1566 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 40 | [SID51086249] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 41 | [SID51086249] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 42 | [SID51086249] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2661, Type: screening] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2661 | | BioAssay type | screening | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 43 | [SID51086249] | Inactive | | | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase [AID2805, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase | | AID | 2805 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 44 | [SID51086249] | Inactive | | | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase [AID2806, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase | | AID | 2806 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 45 | [SID51086249] | Inactive | Potency | | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504466, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504466 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 46 | [SID51086249] | Inactive | Potency | | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 47 | [SID51086249] | Inactive | | | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) [AID493160, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing I (HKDC1) | | AID | 493160 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 48 | [SID51086249] | Inactive | | | uHTS Fluorescent assay for identification of activators of hexokinase domain containing I (HKDC1) [AID493187, Type: screening] | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | uHTS Fluorescent assay for identification of activators of hexokinase domain containing I (HKDC1) | | AID | 493187 | | BioAssay type | screening | | Target | putative hexokinase HKDC1 [Homo sapiens] [gi:156151420] | | PubMed | | | Data Table |  |
|
| 49 | [SID51086249] | Inactive | IC50 | | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay [AID2073, Type: confirmatory] | Mint1 [Rattus norvegicus] [gi:2625023] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay | | AID | 2073 | | BioAssay type | confirmatory | | Target | Mint1 [Rattus norvegicus] [gi:2625023] | | PubMed | | | Data Table |  |
|
| 50 | [SID51086249] | Inactive | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 51086249 | | CID | 24892008 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|